MedTrace Logo

A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study

NCT04562142 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 395

Last updated 2020-09-24

No results posted yet for this study

Summary

The purpose of the study is to collect acoustic, ECG, and clinical data from consenting participants, so that AusculSciences can perform analysis on the sounds produced by the heart and determine the accuracy of the CAD-det System for detecting CAD.

Conditions

Interventions

DEVICE

CAD-det

CAD-det test will be done on participants with suspected CAD clinically referred for ICA at a participating clinical investigation site.

Sponsors & Collaborators

  • Ottawa Heart Institute Research Corporation

    collaborator OTHER

  • AusculSciences Canada Inc.

    lead INDUSTRY

Principal Investigators

  • Ben Chow, MD · Ottawa Heart Institue Research Foundation

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2022-03-31
Completion
2022-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04562142 on ClinicalTrials.gov